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Scanning the human genome at kilobase resolution
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University, Evanston, Illinois 60201, USA; 2Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA;
3Glenbrook High School, Northbrook, Illinois 60062, USA; 4Section of Hematology/Oncology, University of Chicago Medical
Center, Chicago, Illinois 60637, USA; 5Robert H. Lurie Comprehensive Cancer Center, Northwestern University,
Chicago, Illinois 60611, USA
Normal genome variation and pathogenic genome alteration frequently affect small regions in the genome.
Identifying those genomic changes remains a technical challenge. We report here the development of the DGS (Ditag
Genome Scanning) technique for high-resolution analysis of genome structure. The basic features of DGS include (1)
use of high-frequent restriction enzymes to fractionate the genome into small fragments; (2) collection of two tags
from two ends of a given DNA fragment to form a ditag to represent the fragment; (3) application of the 454
sequencing system to reach a comprehensive ditag sequence collection; (4) determination of the genome origin of
ditags by mapping to reference ditags from known genome sequences; (5) use of ditag sequences directly as the sense
and antisense PCR primers to amplify the original DNA fragment. To study the relationship between ditags and
genome structure, we performed a computational study by using the human genome reference sequences as a model,
and analyzed the ditags experimentally collected from the well-characterized normal human DNA GM15510 and the
leukemic human DNA of Kasumi-1 cells. Our studies show that DGS provides a kilobase resolution for studying
genome structure with high specificity and high genome coverage. DGS can be applied to validate genome assembly,
to compare genome similarity and variation in normal populations, and to identify genomic abnormality including
insertion, inversion, deletion, translocation, and amplification in pathological genomes such as cancer genomes.
[Supplemental material is available online at www.genome.org.]
Increasing evidence shows that the genome structure is highly
variable within the normal human population (Iafrate et al.
2004; Sebat et al. 2004; Tuzun et al. 2005; Eichler 2006; Feuk et al.
2006; The Human Genome Structural Variation Working Group
2007). Recent studies also indicate that the genome structure in
pathological situations, such as in cancer, is also highly altered,
reflecting the heterogeneous and progressive nature of disease
cells (Sjoblom et al. 2006; Greenman et al. 2007). Systematic
analysis of normal genome variation will provide fundamental
knowledge to understand the genetic basis for normal human
diversity; comprehensive characterization of pathological ge-
nome alteration will identify genetic factors contributing to par-
ticular diseases, which could be used as diagnostic markers and
therapeutic targets.
Genome structural changes range from whole chromosome
gain or loss, to subchromosomal changes of translocation, am-
plification, inversion, insertion, and deletion, to single nucleo-
tide changes including haplotypes and SNPs. Traditional cytoge-
netic approaches are widely used to successfully identify the
changes at the whole chromosome to subchromosome levels
(Huret et al. 2003). CGH and array-CGH are becoming com-
monly used to identify the changes at megabase to submegabase
levels (Kallioniemi et al. 1992; Pinkel et al. 1998; Cai et al. 2002).
SNP and haplotype studies are enabling the detection of the
variation at the single nucleotide level (Sachidanandam et al.
2001; McCarroll et al. 2006). However, detecting the structural
changes at kilobase to subkilobase levels remains a technical
challenge. Although the genome-tiling array may detect such
changes (Bertone et al. 2004; Cheng et al. 2005; Kim et al. 2005;
Kapranov et al. 2007), its use in genome structural study is re-
stricted by the higher cost, inability to accurately detect the bal-
anced variations of inversion, insertion and translocation, and
inability to detect the genomic contents not present in the ref-
erence genome sequences. Alternatively, the DNA sequencing-
based approach can detect genome structural changes; its power
has been well demonstrated by the fosmid pair-end sequencing
study that detected hundreds of genome variations at 40 kb reso-
lution (Tuzun et al. 2005) and the BAC end-sequencing profiling
study that identified many genetic abnormalities in cancer cells
at 200 kb resolution (Volik et al. 2006). However, the high cost,
the complicated process, and the limited throughput capacity of
the conventional Sanger sequencing system restrict its routine
use for studying genome structure.
Several next-generation DNA sequencing technologies have
recently been developed, such as the 454 pyrosequencing tech-
nology (Margulies et al. 2005). These technologies are less expen-
sive, simplify the sequencing process, and increase the through-
put capacity compared with the Sanger sequencing system, mak-
ing them potentially useful for sequencing-based genome study
(Bentley 2006; Green et al. 2006; Barski et al. 2007; Mikkelsen et
al. 2007; Robertson et al. 2007). To explore the potential of using
next-generation DNA sequencing technologies to study genome
structure, we designed the DGS (Ditag Genome Scanning) tech-
nique aiming to analyze the genome structure at kilobase reso-
lution. The basic concept of DGS is to fragment the whole ge-
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nome into small restriction fragments, to collect two end tags to
form ditags to represent the fragments, to use the 454 pyrose-
quencing system to sequence the ditag population, and to deter-
mine the genome origin of each detected fragment by referring to
known genome sequences. By using the human genome refer-
ence sequences as a model, we performed computational analy-
ses to study the relationship between ditags and genome struc-
ture. We also analyzed the ditags experimentally collected from
GM15510 DNA, which was characterized by fosmid pair-end se-
quencing, and the ditags from the genomic DNA of Kasumi-1, a
human leukemic cell line that has highly altered genome struc-
ture. Our evaluation indicates that DGS provides a powerful tool
for genome structural study.
Results
Design of the DGS technique
The DGS process includes the following major steps (Fig. 1): a
genomic DNA sample is first fragmented by restriction digestion.
The DNA fragments are cloned into plasmid vectors to generate
a genomic DNA library. The library is then digested by MmeI to
retain two short tags on each site of the cloned fragment in the
same vector. The tag-vector-tag fragments are self-ligated to form
a ditag. Ditags are released from the vectors, concatemerized, and
massively sequenced by using the 454 DNA sequencing system.
Ditags are extracted from the sequences based on the restriction
sites. The genome origin of ditags is identified by mapping the
ditags to a reference ditag database preconstructed based on vir-
tual restriction fragments of known genome sequences. Based on
the mapping results, each experimental ditag is classified either
as the mapped ditag representing the DNA fragments with nor-
mal structure, or the trouble-mapped ditag representing
the DNA fragments with different structure (Supplemental Fig. 1).
Computational analysis of DGS ditags
Using the human genome reference sequences (HG18) as a
model, we studied the relationship between ditag and genome
structure.
The total number of ditag-derived bases from 6-base restriction
fragments matches the capacity of the 454 sequencing system
The number of restriction fragments from a genome determines
the number of ditags, and, therefore, the number of total bases to
be sequenced. To control the sequencing cost, we planned to
analyze one genome through one 454 sequencing run that pro-
vides up to 20 Mbs per run (454 GS20 sequencing system). We
analyzed various types of virtual restriction fragments in HG18 to
find the range of the total bases from the corresponding ditags.
The total number of ditag-derived bases from the 6-base restric-
tion fragments is between 2 and 45 Mb (Table 1), a range that
matches the capacity of the 454 sequencing system per run. Since
the total bases from 8-base restriction fragments are far lower
than the range and the 4-base restriction fragments are far higher
than this range (data not shown), the 6-base restriction frag-
ments are suitable for the designed system.
Ditags from 6-base restriction fragments provide high resolution and high
genome coverage
The size of the restriction DNA fragments represents the resolu-
tion. To determine the resolution, we analyzed the size distribu-
tion of virtual 6-base restriction fragments in HG18. The result
shows that the size distribution varies widely, depending on the
type of restriction fragments (Table 1). For example, the total
number of Asp130I fragments is 85,897, but the number in-
creases to 1,306,835 for the PstI fragments, due mainly to the
changes in the number of smaller fragments. At a 6-kb cut-off,
the number of fragments shorter than 6 kb varies over 75-fold
between Asp130I fragments and PstI fragments (15,454 for
Asp130I fragments vs. 1,169,283 for PstI fragments). In contrast,
the number of fragments longer than 6 kb is rather constant
between different types of restriction fragments, e.g., the number
of fragments longer than 6 kb differs less than twofold between
Asp130I and PstI fragments (70,443 for Asp130I fragments vs.
137,552 for PstI fragments). Although the absolute number of
longer fragments remains stable in different types of 6-bp restric-
tion fragments, its proportion decreases substantially in higher
frequency restriction fragments. Therefore, the resolution of de-
tection can be predetermined by selecting different types of
6-base restriction fragments. By targeting higher frequency re-
striction fragments, higher resolution and higher genome cover-
age can be attained. For example, SacI generates 599,852 frag-
ments, of which 71% are shorter than 6 kb and 23% are shorter
than 1 kb (Fig. 2).
Ditags provide high specificity to represent the original DNA fragments
Ditags have short sequences (on average 34 bp/ditag). We sought
to determine whether the ditag population is highly specific in
representing their original DNA fragments at the genome level.
Our study shows that this is indeed the case. Taking the ditags
from SacI fragments as an example. For the 599,805 ditags ex-
tracted from these fragments, 94% (565,472) map back specifi-
cally to their original fragments. The high specificity is consistent
across different chromosomes except chromosome Y (Table 2A).
Furthermore, not only ditags from the nonrepetitive sequences,
Figure 1. Schematics of the DGS process. See Results section for de-
tailed explanation.
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but ditags from the repetitive sequences are also highly specific.
Half of the human genome is composed of repetitive DNA. Con-
sequently, 27% of ditags are from the purely repetitive DNA frag-
ments and 40% of ditags are from the fragments across the non-
repetitive and the repetitive DNA (a ditag whose one single tag is
from the nonrepetitive region and the other is from the repetitive
region). For the ditags from the purely repetitive DNA fragments,
88% remain specific; for the ditags across the repetitive and non-
repetitive regions, 97% are specific (Table 2B). The high specific-
ity of ditags for the repetitive DNA fragments enables use of ditag
to analyze the structure in the repetitive regions of the genome.
Ditag allows for comparison of the similarity and differences
between different genomes
In addition to the human genome reference sequences generated
by the Human Genome Project, several individual human ge-
nomes have recently been sequenced and are publicly available.
Using Venter’s genome sequences and HG18 as models, we
evaluated the utility of ditags from individual genomes for com-
paring structural similarities and differences between different
genomes. Comparison of the SacI ditags from the two genome
sequences shows that 95.9% ditags from Venter’s genome are the
same as that from HG18, implying that the DNA fragments rep-
resented by these ditags in Venter’s genome have the same struc-
ture as the corresponding ones in the HG18. However, 4.1% di-
tags from Venter’s genome cannot be mapped to HG18 ditags.
These ditags represent the DNA fragments that are different be-
tween Venter’s genome and HG18 (Table 3). The comparison also
shows that HG18 provides higher genome coverage than Ven-
ter’s genome sequences, as reflected by its higher number of total
ditags, unique ditags, and unmapped ditags that represent the
DNA fragments not included in Venter’s genome sequences.
Therefore, the HG18 should be used as the optimal genome ref-
erence for ditag mapping study.
Experimental analysis of DGS ditags
To evaluate DGS experimentally, we collected ditags from
GM15510 DNA. The same DNA was used for the construction of
a fosmid library. This library was pair-end sequenced extensively,
with the collection of 1.7 Gb (International Human Genome
Study Consortium 2004). These sequences were used for studying
genome variation with the identification of 297 variations in the
GM15510 genome that differ from the human genome reference
sequences (Tuzun et al. 2005). Ditags collected from the same
DNA sample are evaluated with the existing rich genomic infor-
mation, which serves as a control to evaluate DGS for detecting
genome structural changes.
Experimental ditag collection
We analyzed two types of restriction fragments from GM15510
DNA: the SacI fragment that has a modest restriction frequency,
and the HindIII fragment that has higher restriction frequency
(Table 1). By using one 454 GS20 sequencing run, we collected
160,537 raw sequences of 14 Mb from SacI and HindIII ditags.
From those sequences, we identified 331,010 ditag copies and
81,890 unique ditags including 46,354 SacI ditags and 35,536
HindIII ditags (Table 4; Supplemental Table 1). The coverage is
about 10% for SacI ditags and 5% for HindIII ditags for fragments
<6 kb that are clonable by plasmid vector, or 8% for SacI ditags
and 4% for HindIII ditags for all fragments of the genome (Table
1). The ratio between the total collected ditag copies and the total
Figure 2. Size distribution of DNA fragments represented by ditags.
The empty columns show the size distribution of the total virtual SacI
DNA fragments from HG18, and the filled columns represents the size
distribution of the virtual DNA fragments in HG18 mapped by GM1510.
SacI ditags are shown.
Table 1. Number of fragments and ditag bases by 6-base restriction enzymes in HG18
Enzyme Restriction site Total
Fragments (%)
Fragment >6 kb Ditag bases Fragment <6 kb Ditag bases
PstI CTGCAG 1,306,835 137,552 (11) 4,676,768 1,169,283 (89) 39,755,622
NsiI ATGCAT 928,031 167,257 (18) 5,686,738 760,774 (82) 25,866,316
HindIII AAGCTT 842,432 153,346 (18) 5,213,764 689,086 (82) 23,428,924
XbaI TCTAGA 804,875 160,840 (20) 5,468,560 644,035 (80) 21,897,190
EcoRI GAATTC 783,915 161,487 (21) 5,490,558 622,428 (79) 21,162,552
BglII AGATCT 775,788 160,909 (21) 5,470,906 614,879 (79) 20,905,886
SacI GAGCTC 599,852 171,436 (29) 5,828,824 428,416 (71) 14,566,144
SphI GCATGC 549,919 180,263 (33) 6,128,942 369,656 (67) 12,568,304
ScaI AGTACT 543,087 174,386 (32) 5,929,124 368,701 (68) 12,535,834
ApaI GGGCCC 462,363 144,722 (31) 4,920,548 317,641 (69) 10,799,794
EcoRV GATATC 433,575 170,269 (39) 5,789,146 263,306 (61) 8,952,404
SpeI ACTAGT 395,746 169,476 (43) 5,762,184 226,270 (57) 7,693,180
BamI GGATCC 350,470 152,405 (43) 5,181,770 198,065 (57) 6,734,210
KpnI GGTACC 288,593 151,244 (52) 5,142,296 137,349 (48) 4,669,866
XhoI CTCGAG 121,323 87,780 (72) 2,984,520 33,543 (28) 1,140,462
Asp130I ATCGAT 85,897 70,443 (82) 2,395,062 15,454 (18) 525,436
Seventeen bases from each end of a fragment were used for calculating the ditag bases.
High-resolution analysis of human genome structure
Genome Research 753
www.genome.org
 Cold Spring Harbor Laboratory Press on August 25, 2011 - Published by genome.cshlp.orgDownloaded from 
unique ditags is about 4:1. In general, the SacI and HindIII data
collections are consistent.
Constructing a comprehensive ditag reference database
We developed a comprehensive reference ditag database to de-
termine the genome origin of the detected ditags. This database
contains virtual ditags extracted from virtual restriction frag-
ments in HG18. In addition, the database also includes reference
ditags containing known SNP to identify the experimental ditags
containing SNP. Taking advantage of the high-sequence similar-
ity between the human genome and the chimpanzee genome (Li
and Saunders 2005), reference ditags were also extracted from the
chimpanzee genome reference sequences to identify the ditag
whose original fragment is not included in the human genome
reference sequences, but which has a homologous counterpart in
the chimpanzee genome sequences. The reference database also
includes the reference ditags extracted from the variation se-
quences determined by the GM15510-derived fosmid pair-end
sequencing. To identify the ditags from the variations in the
available individual human genome sequences, ditags were also
extracted from the Celera human genome sequences, the Venter
genome sequences, and the unassembled Watson 454 genome
sequences. Supplemental Table 2 summarizes the reference ditag
information.
The majority of ditags detected in GM15510 maps to the human genome
reference sequences
The experimental ditags were mapped first to the reference ditags
of HG18. Two-base mismatch was allowed for the ditags not
mapped to the reference ditag in order to cover the ditags con-
taining potential sequencing error or SNP. 454 Sequencing can-
not determine the precise number of homobases in the homo-
polymer region (Goldberg et al. 2006). To address this issue, the
unmapped ditags with homopolymer bases were identified and
mapped to the reference ditags by allowing multiple mismatches
for the homobases (Ng et al. 2006). Through these processes,
86.7% of ditags were identified as the mapped ditags, including
78% as the perfectly mapped ditags, 4.8% as the ditags contain-
ing sequencing errors or unknown SNP, 0.3% as known SNP-
containing ditags, and 2.1% as homopolymer ditags (Table 4).
The mapping specificity is equivalent to that of the computa-
tional analysis (Supplemental Tables 2, 3). In addition, the ditags
mapped solely to the chimpanzee genome sequences account for
0.6% of the total ditags (Table 4; Supplemental Table 4). These
ditags likely represent the human DNA fragments missed in the
human genome reference sequences. The high mapping rate in-
dicates that, under the given resolution, most of the DNA frag-
ments in the GM15510 genome detected by ditags have the same
structure as their corresponding fragments in HG18.
Ditag detects shorter DNA fragments
Detection of shorter DNA fragments implies the high resolution
for analyzing genome structure. Computational analysis shows
that the proportion of the fragments shorter than 6 kb is domi-
nant among the total fragments generated by many high fre-
quent 6-base restriction enzymes (Table 1). To verify this feature,
we analyzed the size distribution of the virtual DNA fragments in
HG18 that were detected by the experimental ditags (Fig. 2). Set-
ting 6 kb as the cut-off, 93% of the detected DNA fragments are
shorter than 6 kb, and 43% are shorter than 1 kb. These rates are
even higher than those found for HG18, in which 72% of the
fragments are shorter than 6 kb and 23% of the fragments are
shorter than 1 kb. The higher rate of shorter DNA fragments is
mostly due to the use of plasmid vector for the cloning that
Table 2. Specificity of SacI ditags in the human genome
sequences (HG18)
(A) Ditag from each chromosomea
Chromosome
Total
ditag
Non-specific
ditag (%)
Specific
ditag (%)
1 50,228 2,502 (5) 47,726 (95)
2 47,985 1,727 (4) 46,258 (96)
3 37,363 1,142 (3) 36,221 (97)
4 32,682 1,430 (4) 31,252 (96)
5 34,445 2,107 (6) 32,338 (94)
6 34,938 4,458 (13) 30,480 (87)
7 31,806 1,855 (6) 29,951 (94)
8 28,929 1,215 (4) 27,714 (96)
9 25,537 2,158 (8) 23,379 (92)
10 29,252 1,567 (5) 27,685 (95)
11 30,346 1,316 (4) 29,030 (96)
12 26,467 1,053 (4) 25,414 (96)
13 16,726 484 (3) 16,242 (97)
14 18,386 672 (4) 17,714 (96)
15 18,863 1,384 (7) 17,479 (93)
16 20,214 1,394 (7) 18,820 (93)
17 20,500 1,305 (6) 19,195 (94)
18 14,479 363 (3) 14,116 (97)
19 15,038 837 (6) 14,201 (94)
20 15,206 328 (2) 14,878 (98)
21 7,207 314 (4) 6,893 (96)
22 10,391 574 (6) 9,817 (94)
X 28,420 2,568 (9) 25,852 (91)
Y 4,397 1,580 (36) 2,817 (64)
Total 599,805 34,360 565,472 (94)
(B) Ditags from nonrepetitive and repetitive regionsb
Genomic region
No. of ditag Specific ditagTag1 Tag2
Repetitive Repetitive 159,794 (27) 141,259 (88)
Repetitive Nonrepetitive 119,256 (20) 115,627 (97)
Nonrepetitive Repetitive 119,278 (20) 115,705 (97)
Nonrepetitive Nonrepetitive 201,477 (34) 192,881 (96)
Total 599,805 (100) 565,472 (94)
aA specific ditag refers to a ditag that exists only once in the whole
genome.
bRepetitive region refers the sequences covered by RepeatMasker pro-
gram.
Table 3. Comparison between Venter genome ditags and HG18
ditags
Class Venter’s genomea HG18
Total ditags 527,294 (100) 599,805 (100)
Unique ditags 513,892 (97.5) 565,472 (94.3)
Venter’s genome to HG18
Total 513,892 (100)
Mapped 492,885 (95.9)
Not mapped 21,007 (4.1)
HG18 to Venter’s genome
Total 565,472 (100)
Mapped 492,885 (87.2%)
Not mapped 72,587 (12.8)
SacI ditags from both genomes were used for the comparison.
aGenBank accession nos. ABBA01000001–ABBA01255300 were used for
the analysis.
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preferably clones shorter fragments. Such size distribution en-
sures the kilobase resolution for analyzing genome structure.
Ditag detects DNA fragments that vary from the human genome reference
sequences
A total of 2,298,774 fosmid end sequences were generated from
the GM15510 fosmid library (International Human Genome
Study Consortium 2004). The possible variations affecting
smaller regions in the GM15510 genome could be present in the
sequences. By comparing ditags that are not mapped to HG18 to
these sequences, the variation could be identified. We investi-
gated this possibility. Reference ditags were extracted from the
sequences containing at least two SacI or HindIII sites detectable
by ditags (Fig. 3A). The experimental ditags that do not map to
HG18 were mapped against these reference ditags. A total of 58
experimental ditags was identified to map to the fosmid end
sequences covering 289 bp on average. Comparing each mapped
sequence to HG18 shows variations including novel sequence,
deletion, insertion, and ditag sequence changes, including mu-
tation in the restriction site and mismatch in the tag sequences
(Fig. 3B,C; Supplemental Table 5). Although these variations
were included in the original fosmid sequences, they were not
identified as variations at the 40-kb resolution (Tuzun et al.
2005), but were detected by the ditags with the higher resolution.
Only a few ditag-detected 55 variations overlap with the 297
variations detected in the GM15510 by the fosmid study. This is
likely attributed to the factor that fosmid sequences target large
variations covered by two end fosmid sequences, whereas ditags
target small variations within a single fosmid sequence. Limited
genome coverage by the ditags may also contribute to this issue
(Fig. 6A, below).
Recently, three sets of the human genome sequences have
become publicly available, including the Celera human genome
sequences, the Venter genome sequences, and the unassembled
Watson genome sequences that are the raw 454 sequences of
∼250 bp per sequence. These sequences provide a rich source to
identify the experimental ditags originated from the variations in
individual human genomes. We extracted reference ditags from
these three sets of human genome sequences. Comparing with
these reference ditags shows that, of the experimental ditags not
mapped to HG18, 317 ditags mapped to the Celera genome se-
quences, 552 ditags mapped to the Venter genome sequences,
and 65 ditags mapped to the Watson genome sequence (Table 4;
Supplemental Table 6). The relatively higher mapping rate to the
Venter genome sequences is likely due to the unassembled nature
of the used sequences that contributed more reference ditags
than the assembled sequences; the lower mapping rate to the
Watson genome sequences is due to the short length of the 454
sequences, of which many do not contribute reference ditags
since they do not have two (SacI or HindIII) restriction sites for
reference ditag extraction. Together with the GM15510 fosmid-
sequence mapping results, of the ditags not mapped to HG18 and
chimpanzee genome sequences, 664 ditags mapped to 1007 loci
that contain variations across four individual genomes (Fig. 4A,B;
Supplemental Tables 5, 6). The 664 ditags account for 0.8% of the
total ditags (664/81,890), which approximates the 1% variation
in the GM15510 genome determined at 40-kb resolution (Tuzun
et al. 2005). Most of the 664 ditags map to more than one indi-
vidual genome. For example, of the 169 SacI ditags mapped to
the Celera genome, 149 also mapped to the Venter genome, 10 to
the Watson genome, four to the GM15510 genome, and two
mapped to all four individual genomes. The ditags mapped to
more than one individual genome represent the genome varia-
tions common in these individual genomes.
Ditag detects unknown genome variation
The current knowledge of normal genome variations is still lim-
ited, and many potential genome variations in individual ge-
Table 4. Mapping summary for the ditags collected from GM15510 and Kasumi-1 genomes
Items
GM15510 Kasumi-1
SacI HindIII Total Sac I
Total bases 8,144,009 6,380,307 14,524,316 15,620,663
Total sequences 89,352 71,185 160,537 172,856
Total ditags identified 280,487 260,359 540,846 350,005
Total unique ditags 46,354 (100) 35,536 (100) 81,890 (100) 168,281 (100)
Mapped ditags 40,995 (88.4) 29,972 (84.3) 70,967 (86.7) 123,243 (73.2)
Human genome sequences (HG18) 40,390 (87.1) 29,455 (82.9) 69,845 (85.3) 121,258 (72.1)
Perfect match 37,318 (80.5) 26,564 (74.8) 63,882 (78.0) 109,618 (65.2)
1-base mismatch 2,134 (4.6) 1,850 (5.2) 3,984 (4.8) 7,595 (4.5)
SNP 166 (0.4) 83 (0.2) 249 (0.3) 435 (0.3)
Homopolymer 772 (1.7) 958 (2.7) 1,730 (2.1) 3,610 (2.1)
Chimpanzee genome sequences 277 (0.6) 181 (0.5) 458 (0.6) 787 (0.5)
Human genome variationsa 328 (0.7) 336 (0.9) 664 (0.8) 1,198 (0.7)
GM15510 fosmid sequences 35 38 73 96
Celera human genome sequences 169 148 317 604
Venter genome sequences 273 279 552 991
Watson genome sequences 30 35 65 270
Trouble mapped ditags 5,359 (11.6) 5,564 (15.7) 10,923 (13.3) 45,038 (26.8)
Two single tags mapped 3,739 (8.1) 4,541 (12.8) 8,280 (10.1) 35,806 (21.3)
Both mapped to one location 168 121 289 1,654
One mapped to multiple locations 1,359 1,185 2,544 11,648
Both mapped to multiple locations 2,212 3,235 5,447 22,504
Only one single tag mapped 1,499 (3.2) 984 (2.8) 2,483 (3.0) 9,174 (5.5)
Both single tags do not map 121 (0.3) 39 (0.1) 160 (0.2) 58 (0.04)
aThe 664 GM15510 ditags map to 1007 loci, and the 1198 Kasumi-1 ditags map to 1961 loci in different genomes. Those ditags mapped to more than
one individual genome were counted only once.
High-resolution analysis of human genome structure
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nomes remain to be identified. The ditags not mapped to existing
genome sequences provide a resource to identify unknown ge-
nome variations. An alternative mapping approach was devel-
oped to explore this possibility. In this approach, an experimen-
tal ditag not mapped to the reference ditags was first separated
into two single ditags, and each single tag was then mapped
individually to reference ditags. Using this approach, the major-
ity of the ditags previously not mapped to the reference ditags
becomes mapped (Table 4), including ditags with both single tags
being mapped and with only one single tag being mapped. Be-
cause of the decreased specificity of single tag mapping, however,
a single tag could map to multiple location in the genome. For
the ditags with both single tags mapped, we divided these into
three groups, including group one, in which both mapped to
single location, group two, in which one mapped to multiple
locations, and group three, in which both mapped to multiple
locations. Of these three groups, group one provides the highest
mapping accuracy, and group three the lowest mapping accu-
racy. We predicted the variations of insertion, deletion, inver-
sion, and translocations for ditags in group one and group two.
No predictions were made for group three because of the low
mapping specificity (Supplemental Tables 1, 8). Ditags with two
unmapped single tags may represent the DNA fragments not in-
cluded in the human genome reference sequences. However,
each subgroup may also contain artificial ditags generated by
cloning and sequencing errors (see Discussion).
Ditag detects chromosome Y fragments
GM15510 is from a female and, therefore, it has no Y chromo-
some. However, a group of ditags mapped to the reference ditags
from the Y chromosome (Supplemental Table 7). We searched
the ditag-covered Y chromosome fragment sequences in the en-
tire genome. Eight loci were identified in chromosomes 1, 8, 9,
10, and 13, but none in chromosome X. Each mapped autosome
locus is located within a functional genes, but this is not the case
for its counterpart in Y chromosome (Table 5A). Four of these
autosome loci, including three SacI fragments and one HindIII
fragment, are clustered in chromosome 10 within the first intron
of the FANK1 gene (Fibronectin type 3 and ankyrin repeat do-
Figure 3. New variations identified by GM15510 ditags. (A) Compari-
son between ditags and fosmid sequences. Reference ditags were ex-
tracted from fosmid sequences with two restriction sites. Experimental
ditags not mapped to HG18 were compared with the fosmid reference
ditags to identify the variations within the fosmid sequences. (B) Sum-
mary of the results. Comparing the GM15510 experimental ditags to the
reference ditags of GM15510 fosmid sequences identified 55 variations.
(C) Example of an insertion variation detected by a ditag. This insertion
was identified in a fosmid sequence (TI number 146956937) by a ditag
AAGCTTTAACACCGTG/GTTTCTTCAAAAGCTT (See Supplemental Table
4). The tag 1 was released from a SacI site in the fosmid sequence, which
does not exist in HG18. The fosmid sequences covered by the ditag
contain a 24-base insertion.
Figure 4. Genome variations in four individual genomes detected by
ditags. The GM15510 ditags not mapped to HG18 were mapped against
the reference ditags from the four human genome sequences of
GM15510 fosmid sequences, Celera genome sequences, Venter genome
sequences, and Watson genome sequences.
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mains protein 1), a gene containing six ANK repeats and a fibro-
nectin type-III domain (Table 5B). Two of the chromosome 10
fragments were also detected in Kasumi-1 genome, which also
lacks Y chromosome (see below).
Ditag detects cancer genome alterations
Cancer genome structure can be substantially altered from nor-
mal genome. We used Kasumi-1 cells as a model to test the power
of DGS in detecting genome alterations. Kasumi-1 is a leukemic
cell line whose genome varies greatly from the normal genome,
as reflected by its complicated karyotype (Asou et al. 1991; Hors-
ley et al. 2006; Supplemental Fig. 1). We collected ditags from
Kasumi-1 SacI DNA fragments by using a single 454 sequencing
run that doubled the ditag detection over the GM15510 SacI
restriction fragments (Table 4; Supplemental Table 8). The ditags
collected provide 39% coverage for the fragments <6 kb in HG18,
or 28% for the total genome fragments in HG18. The experimen-
tal ditags were processed by using the established ditag mapping
procedure. The results show the following features.
● Large genome size. Under a defined scale of ditag sequencing,
the ratio between the number of total ditag copies and the
number of total unique ditags reflects the relative size of dif-
ferent genomes. The lower ratio represents the larger size and
the higher ratio represents the smaller size of the genome. In
Kasumi-1, the ratio is 2:1 (350,005 SacI ditag copies generate
168,281 unique ditags), whereas in GM15510 ditags, the ratio
is 6:1 (280,481 SacI ditag copies generate 46,354 unique di-
tags). Consistent with the results from Kasumi-1 karyotyping
that show many extra genome contents such as the trisomy 3
and trisomy 8, the size of the Kasumi-1 genome is substantially
larger than the GM15510 genome.
● High frequent genome structural alteration. This is reflected by
the high rate of Kasumi-1 ditags not mapped to the human
genome reference sequences. Compared with the 86.7% in
GM15510, only 73.2% are the mapped ditags in Kasumi-1 di-
tags. The difference is due largely to the lower rate of perfectly
mapped ditags: only 65.2% of Kasumi-1 ditags are perfectly
mapped to HG18 in contrast to 78% in GM15510. The lower
mapping rate leads to a higher incidence of trouble-mapped
ditags: 26.8% of Kasumi-1 ditags are the trouble-mapped di-
tags, compared with 13.3% of the GM15510 ditags.
● Presence of normal genome variations. Mapping the ditags to
the four individual human genome sequences identified 1198
ditags that represent the variations in normal human genomes
(Fig. 4C; Supplemental Table 9). The rate (0.7%) is similar to
the one observed in GM15510 ditag-mapped variations (0.8%).
Considering that the scale of Kasumi-1 SacI ditag collection
doubled that of GM15510, we tested whether the increased
ditag detection could detect more variations in GM15510 ge-
Table 5. Mapping ditag-detected chromosome Y fragments to autosomes
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nome identified by fosmid sequencing. We compared all Ka-
sumi-1 ditags with the reference ditags extracted from the 33
fully sequenced fosmid clones containing the 297 variations.
Of the 307 SacI reference ditags from these clones, 123 are
mapped by the Kasumi-1 ditags, of which 116 ditags are com-
mon to the HG18, whereas seven ditags are located in the
variations of four insertions and one deletion in five fosmid
clones (Fig. 5A; Supplemental Table 10A). For example, the
fosmid variation AC153461 contains an 8002-bp insertion that
does not map to HG18. Ten reference ditags are present in this
sequence and six are located within the insertion. Of these six
reference ditags, five were detected by Kasumi-1 ditags, two of
which are across the junctions between the normal sequences
and the insertion, and three are purely located within the in-
sertion (Fig. 5B; Supplemental Table 10B). The mapping of Ka-
sumi-1 ditags to the normal variation ditags indicates that Ka-
sumi-1 genome contains the genome variations present in the
normal individual genomes.
● Chromosome Y fragments remaining in Kasumi-1 genome. Ka-
sumi-1 cells originated from a male, but karyotype analyses
consistently show that the whole Y chromosome is lost from
the cell (Asou et al. 1991; Supplemental Fig. 1). However, 11
ditags map specifically to the reference ditags of chromosome
Y (Supplemental Table 7), of which three were also detected in
GM15510, and their covered sequences were located in chro-
mosomes 9 and 10 (Table 5). The presence of eight Y chromo-
some-specific ditags indicates that these chromosome Y frag-
ments did not disappear but integrated into other chromo-
some(s) in the Kasumi-1 genome.
Amplifying ditag-detected DNA fragment by using ditag sequences
Although informatics analysis can identify the ditags represent-
ing DNA fragments with normal structure or with abnormal
structure, physically isolating and sequencing the ditag-detected
DNA fragments will be useful to confirm the mapping results and
for further study. A ditag is from two ends of a short DNA frag-
ment within a kilobase(s). With 16-bases in each single tag, the
two single tags in a ditag can readily serve as the sense and an-
tisense PCR primers to amplify its original DNA fragment. Using
this approach, we analyzed 16 GM15510 SacI ditags from the 55
ditag-mapped fosmid end sequences (Fig. 3A) by using the
GM15510 DNA as the templates, and 11 ditags were confirmed
(Supplemental Table 11A). Five SacI ditags that mapped to fos-
mid sequences were further tested in a panel of DNA samples of
10 individuals. The result shows that two represent the DNA
fragments commonly present in all 10 individuals, and three
represent the DNA fragments only existing in five individuals
(Fig. 6; Supplemental Table 11B). Further testing of five HindIII
ditags in the same DNA panel shows that nearly all are present in
each of the 10 individual genomes (Supplemental Fig. 4; Supple-
mental Table 11B). Sequencing the amplified DNA using differ-
ent types of ditags including the mapped ditags, the SNP ditags,
and the trouble-mapped ditags shows that 60% are consistent
with the ditag mapping results (Supplemental Table 12; Supple-
mental Fig. 2).
Discussion
Genomic changes affecting small regions exist widely across the
human genome (Mills et al. 2006). These genomic changes may
Figure 5. Kasumi-1 genome contains the variations in the GM15510
genome detected by fosmid sequences. (A) Summary of the mapping
between the Kasumi-1 ditags and the reference ditags extracted from the
variations in the 33 fully sequenced fosmid clones. Four insertion varia-
tions were detected by Kasumi-1 ditags that detected the junction and
the insertion sequences. (B) Example of the insertion confirmed by ditags.
Variation AC153461 contains an 8002-bp insertion. Six ditags detected
this insertion, four of which were within the insertion, and two crossed
the junctions between the normal sequences and the insertion. (S) SacI
restriction site.
Figure 6. Ditag-detected genome variations in multiple individual ge-
nomes. Variations in GM15510 detected by five SacI ditags (Supplemen-
tal Table 12B) were tested in a panel of 10 DNA samples (Coriell). (GM)
GM15510 DNA was used as the positive control. The results show that
two variations are present in all 10 individual genomes and three varia-
tions exist in only four individual genomes.
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play critical roles in various biological processes, such as genome
stability, phenotypes, and diseases. While comprehensive iden-
tification of these genomic changes is essential, it remains a tech-
nical difficulty. Aiming to provide a tool for high-resolution
analysis of genome structure, we developed the DGS technology.
DGS integrates multiple concepts into a linear system, including
restriction digestion for breaking the genome into small frag-
ments, pair-end sequencing used in BAC and fosmid sequencing
for structural analysis (International Human Genome Study Con-
sortium 2004; Volik et al. 2006), ditag sequencing used in ChIP-
PET for detecting protein-bound DNA fragments (Wei et al. 2006;
Dunn et al. 2007), 454 sequencing technology for massive se-
quencing collection (Margulies et al. 2005), and the known ge-
nome sequences as the references for determining the genome
origin of the detected ditags. Compared with fosmid pair-end
sequencing, DGS increases the resolution toward the kilobase
level, thus significantly increasing the power of detecting the
variation affecting smaller loci in the genome.
Recently, a technology termed Paired-End Mapping (PEM)
was reported (Korbel et al. 2007). While both PEM and DGS aim
to analyze genome structure at high-resolution by targeting the
two end sequences of the DNA fragments, significant differences
exist between these two approaches:
● Different sources of the end sequences. DGS tags are from a
specific type of restriction fragments, whereas PEM tags are
from randomly generated fragments.
● Different resolutions. By selecting highly frequent restriction
fragments, DGS provides higher resolution toward subkilo-
bases, whereas PEM provides >3 kb resolution.
● Different lengths of tag sequences. DGS only sequences 32 bp
for each detected fragment, whereas PEM sequences over 100
bases for each detected fragment.
● Adaptation to different next-generation sequencing systems.
The short ditag (32 bp) enables DGS to use all three types of
next-generation DNA sequencers for ditag collection (the 454
system [100–200 bp/read], Illumina’s Genome Analyzer [35–50
bp/read], or AB’s SOLiD system [35 bp/read]); only the 454
system can be used for PEM. The much higher sequencing
productions of Genome Analyzer (>1 Gb/run) and SOLiD (>1
Gb/run) over 454 system (100 Mb/run) allow DGS to target
higher frequent restriction fragments to reach higher genome
coverage and resolution.
● Different mapping processes. To determine the genome origin,
DGS ditags map to a preconstructed reference ditag database
based on the same type of restriction fragments. The ditag
mapping is a simple process that takes minutes to complete the
mapping analysis for a full set of ditags in a regular desktop
computer. The PEM mapping process is challenging. Because
PEM sequences are from randomly generated DNA fragments,
each sequence must search against the entire genome. Map-
ping millions of PEM tag sequences in one data set requires the
exhaustive use of large computational power. For example,
200,000 cpu hrs on 440 processors were used to map one set of
PEM data to the human genome reference sequences (Korbel et
al. 2007). The same issue exists for mapping CHIP-PET ditags to
the reference genome sequences, as these ditags are also from
the randomly generated DNA fragments (Chiu et al. 2006).
● Different mapping rates. The mapping rate of DGS ditag is
much higher (78% of GM15510 ditags, but only 63% of PEM
sequences mapped perfectly to HG18). This is largely due to
the fact that a DGS ditag is used as a single unit for mapping,
whereas the PEM maps the two end sequences separately (Kor-
bel et al. 2007).
● Different size of DNA fragments for PCR amplification. The
smaller size of fragment represented by ditags than that de-
tected by PEM makes it easier to be amplified by regular PCR.
● Different lengths of sequences for PCR primer design. DGS
ditags provide only 16 bp for primer design, resulting in limi-
tations; PEM provides longer sequences, facilitating better
primer design.
Determining genome origin of experimental ditags depends
on the reference ditag database. Although they provide the ma-
jority of the reference ditags representing the common structure
in different individual genomes, the human genome reference
sequences were derived from a few individual genomes that lack
genome variation information in the human population (Feuk et
al. 2006). Therefore, including other genome sequences as the
reference ditag sources should help to identify the genome origin
of ditags that represent genome variations in different individual
genomes. In our study, we constructed a reference ditag database
that contains reference ditags extracted from the human genome
reference sequences, the SNP sequences, the GM15510 genome
fosmid sequences, the Celera genome sequences, the Venter ge-
nome sequences, and the Watson genome sequences. This com-
prehensive reference ditag database has been very useful for iden-
tifying the ditags originated from not only the common parts,
but also the variable parts among the human genomes. For ex-
ample, 249 ditags from GM15510 were identified as SNP-
containing ditags, and 1010 ditags were identified as the ditags
representing human genome variations. The reference ditag da-
tabase can be continuously expanded to include new genome
information, such as these from the database of genome variants
(http://projects.tcag.ca/variation/), new genome variations
soon to be identified by the Human Genome Variation Project
(The Human Genome Structural Variation Working Group
2007), and the newly initiated 1000 Human Genome Project
(Hayden 2008).
The detection of Y chromosome ditags in both GM15510
genome and Kasumi-1 genome raises an interesting issue for the
origin of Y chromosome. GM15510 is from a female origin, there-
fore, its genome does not have Y chromosome; the Y chromo-
some is absent in Kasumi-1 genome, although it was from male
origin. Both GM15510 and Kasumi-1 therefore provide a model
to identify the origin of Y chromosome. It is considered that
autosomes are the origin of sex chromosomes, including X and Y
chromosomes, and X contributed a substantial portion of Y chro-
mosome (Bishop et al. 1984; Skaletsky et al. 2003). Therefore, it
would be expected that many ditag-detected Y fragments should
map to X chromosome. However, all eight Y ditag-detected Y
fragments map to autosomes (Table 5). This suggests that the
autosomes might directly contribute more contents of Y chro-
mosome than previously thought. In addition, six of the eight
detected Y chromosome ditags contain repetitive Y sequences,
confirming that ditag can be used for analyzing the structure of
repetitive regions that are difficult to analyze so far (Table 2B).
It is unclear whether the normal genome variation is also
widely preserved in pathological genomes. In the Kasumi-1 ditag
mapping study, 1% of ditags map to normal genome variations
distributed in the four individual human genomes, which is close
to the 1.2% observed in the GM15510 DNA. This result clearly
shows that a pathological genome can also contain normal ge-
nome variations. Therefore, when using the genetic changes
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identified in a pathological genome as potential disease markers,
they must be distinguished from normal genome variation.
The trouble-mapped ditags contain information reflecting
genetic variations, but may also include experimental artifacts
generated during cloning and sequencing processes. For ex-
ample, many trouble-mapped Kasumi-1 ditags can be classified to
represent “translocation,” as each of their single tags mapped to
different chromosomes (Supplemental Table 8). However, certain
“translocation” ditags are likely from cloning artifacts in which
two fragments of different chromosome origin were ligated to-
gether and cloning into a single vector that contributes to an
artificial “translocation” ditag. Similar results were also observed
in mRNA ditags used in fusion transcript detection, in which a
substantial number of ditags representing “fusion transcripts”
could not be verified (Ruan et al. 2007) and in PEM tags that were
estimated to account for ∼2% of total PEM tag sequences (Korbel
et al. 2007). Because the probability of forming the same false
“translocation” ditag will be rare among the total fragments,
these artificial ditags could be largely excluded by eliminating
the trouble-mapped ditags with single copy. In addition, the use
of ditag sequences as PCR primers has its limitation. Each tag
consists of only 16 bases, and not all tags provide ideal sequence
composition as PCR primers. These factors could affect the effi-
ciency and specificity of PCR amplification.
In summary, DGS technology provides a useful tool for
studying genome structure. It can be applied to validate genome
assembly, to compare the genome similarity and variation in
normal populations, and to identify genomic abnormalities in-
cluding insertion, inversion, deletion, and translocation in
pathological genomes, such as cancer genomes.
Methods
Computational ditag analysis
The human genome sequences (HG18, http://genome.ucsc.edu/)
were used for this study. Virtual restriction fragments from dif-
ferent restriction sites were generated from the sequences. A 17-
bp tag was extracted from the virtual fragment of both 5 end and
3 end. The two 17-bp tags were then connected to form a virtual
ditag to represent the original virtual DNA fragment. The geno-
mic location of each virtual ditag and its original virtual DNA
fragment were recorded. Various programs written in Perl were
used to study the correlation between the ditags and the genome
sequences.
DGS process
Human DNA samples of GM15510 (Coriell) and Kasumi-1 were
used for DGS ditag collection. The detailed DGS protocol is pro-
vided in the Supplemental material. Briefly, genomic DNA was
fractionated by SacI or HindIII restriction digestion. The pZErO
vector (Invitrogen) was modified, whereby four wild-type MmeI
sites were mutated and two MmeI sites were introduced into the
polylinker region next to the SacI or HindIII site. The digested
DNA sample was dephosphorylated by phospatase to prevent
fragment–fragment ligation, and cloned into the vector to gen-
erate a genomic DNA library. The library was then digested by
MmeI. The tag-vector-tag fragments were purified and religated
to form a ditag library. Ditags from the propagated ditag library
were released by SacI or HindIII digestion, purified, and concate-
merized by using T4 DNA ligase. The concatermers at 200–500 bp
were purified and cloned into the p454-SacI or HindIII vector
containing the 454 adaptor sequences (5GCCTCCCTCGCGC
CATCAG-3, 5GCCTTGCCAGCCCGCTCAG-3) to form a ditag
concatemer library. After library propagation, the concatemers
were released from the library by EcoRI and HindIII digestion for
the SacI ditag library or NotI digestion for the HindIII ditag li-
brary, and gel purified for 454 DNA sequencing collection.
Construction of reference ditag database
The following sequences were used for the construction of the
ditag reference database: Human genome reference sequences
HG18: http://hgdownload.cse.ucsc.edu/goldenPath/hg18/
bigZips/; human dbSNP 126: http://www.ncbi.nlm.nih.gov/SNP/)
ftp://ftp.ncbi.nih.gov/snp/organisms/human_9606/; Chimpan-
zee genome reference sequences: PanTro2, March 2006: http://
hgdownload.cse.ucsc.edu/goldenPath/panTro2/bigZips/; GM15510
fosmid paired-end sequences: http://www.ncbi.nlm.nih.
gov/Traces/trace.cgi?&cmd=retrieve&val=CENTER_PROJECT
%20%3D%20%22G248%22&size=0&retrieve=Submit; Celera
genome sequences: http://www.ncbi.nlm.nih.gov/sites/entrez?db=
genomeprj&cmd=Link&LinkName=genomeprj_nuccore_
wgs&from_uid=1431; Venter genome sequences: ftp://
ftp.ncbi.nih.gov/pub/TraceDB/Personal_Genomics/Venter/; Watson
raw 454 genome sequences: ftp://ftp.ncbi.nih.gov/pub/TraceDB/
Personal_Genomics/Watson/.
Reference ditags were extracted from virtual restriction frag-
ments of each type of DNA sequence, following the same ap-
proach described above (Computational ditag analysis). Ditags
containing SNPs within the 10 bases were identified by referring
to the SNP information and the SNP-ditags were generated by
replacing the bases with the SNPs at the corresponding positions.
The reference ditags extracted from each type of genome se-
quences are listed in a Web site (http://projects.bioinformatics.
northwestern.edu/sanmingwang/).
Ditag mapping
Ditags were extracted from raw 454 sequences based on SacI or
HindIII restriction sites. Each ditag was extracted as 32 bases with
16 bases from each single tag. Ditags containing less than 32
bases were discarded. For mapping to the reference ditags, all
experimental ditag data were imported into the reference ditag
database using Microsoft Access. Initial mapping was done with
exact matches between the experimental ditags and HG18 refer-
ence ditags. For these unmapped experimental ditags, 1 base mis-
match in each single tag was allowed for the mapping. Possible
homopolymer ditags were identified from the nonmapped ditags
by searching ditags with more than two homobases. One base of
these ditags was stretched, e.g., AAA → AAAA, or shortened, e.g.,
AAA → AA, and one base at the end of a single stretched tag was
removed to retain the normal length of the regular ditag, or one
base of the shortened tag was added at the end of a single tag to
create four possible cases of A, C, G, and T. These ditags were
mapped to the reference ditags again. Exact match was done
using SQL commands in Microsoft Access. Based on mapping
results, ditags were classified as the mapped ditags or trouble-
mapped ditags.
Amplifying the DNA fragments detected by ditags
Supplemental Material provides a detailed protocol. In brief, each
single tag of 16 bases in ditag sequences was used to design a
sense primer and an antisense (reverse/complementary) primer,
with four extra bases (ATTC) added to the 5 end of the sense
primer and TTAG to the 5 end of the antisense primer to increase
the primer length to 20 bp. PCR was performed for 30 cycles at
95°C for 30 sec, 60°C for 30 sec, and 72°C for 60 sec. PCR prod-
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ucts were checked on 2% agarose gels, or cloned into the pGEM-T
vector (Promega) for sequencing confirmation. The resulting se-
quence was mapped to the human genome reference sequences
through the UCSC genome browser (http://genome.ucsc.edu/
cgi-bin/hgGateway). To determine whether the genome varia-
tions detected by ditags are present in different individual ge-
nomes, a Coriell human DNA panel (Human Variation Panel–
Caribbean [GM17350–GM17359]) was used as the templates
(http://ccr.coriell.org/).
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